Maturation-promoting factor (MPF), which is functionally defined by Its ability to induce frog oocyte maturation independent ofprotein synthesis, is hypothesized to be the mitotic inducer in eukaryotic cells. Previous studies have demonstrated that the cdc2 protein kinase complex (p34c-cyclin) meets the criteria for MPF. In the present study, we
In the last two decades, the study of mitotic or meiotic (M phase) induction in the eukaryotic cell cycle has focused on maturation-promoting factor (MPF) (1) . MPF was originally defined as an activity in the cytoplasm of mature frog oocytes that could induce maturation (meiotic division) in immature frog oocytes, bypassing the natural process mediated by progesterone (2, 3) . MPF exhibits several critical properties (4, 5) . (i) MPF induces oocyte maturation independent of protein synthesis, which is required for progesteroneinduced oocyte maturation. This property positions MPF activation downstream ofthe step requiring protein synthesis in the maturation-induction pathway. (ii) MPF amplifies itself upon microinjection into immature oocytes. This property of MPF suggests the existence of an autoactivation step during the maturation-induction pathway, in which a catalytic amount of active MPF generated via progesterone stimulation activates the entire pool of a preexisting latent form of MPF. (iii) MPF activity exists in M phase cells of all species tested, suggesting that it is highly conserved. (iv) MPF activity oscillates during the cell cycle in tandem with the onset and maintenance of M phase under both physiological and experimental conditions. Almost 20 yr after its discovery, MPF was purified to near homogeneity from Xenopus and starfish oocytes (6, 7) , although the recovery was low ( 1%). Significantly, as a result ofthis purification, one component ofthe purified MPF was discovered to be the 34-kDa gene product of cdc2 (p34cdc2) (7, 8) , which, based on genetic studies in yeast, is essential for entry into mitosis and encodes a highly conserved kinase (9) . p34cdc2 is complexed with cyclin and is the major M phase-specific H1 kinase (10, 11) . Consequently, MPF, originally defined as a biological activity, could now be associated with a specific molecule, namely p34cdc2-cyclin or the cdc2 kinase complex.
In the present study, we addressed the question whether the cdc2 kinase complex is the only molecular species that meets the criteria for MPF. This question was raised for several reasons. For example, although Labbe et al. (7) showed that MPF copurified with H1 kinase in each of six successive chromatographic fractionations of starfish oocyte extract, Gerhart et al. (5) and Nguyen-Gia et al. (12) observed that MPF and histone kinase activities did not copurify during chromatography of Xenopus egg extract. In addition, we have shown that the mitosis-specific monoclonal antibody (mAb) MPM-2 inhibits Xenopus oocyte maturation and depletes MPF activity from both unfertilized Xenopus egg extract and mitotic HeLa cell extract (13) but does not recognize the cdc2 kinase complex (14) . These facts suggested that MPF activity in the M phase extract might involve more than one factor and, thus, a more comprehensive investigation of MPF activity in M phase extract was required. Preparation of Unfertilized Egg Extracts. Unfertilized eggs were collected and dejellied as described (14) . Egg extract was prepared according to Wu and Gerhart (15) tTo whom reprint requests should be addressed.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. dithiothreitol, and a mixture of protease inhibitors (13) . One micromolar ATP or 2 mM ATP[yS] were added as described in text. The homogenate was centrifuged at 40,000 rpm with a Beckman Ti5O rotor for 1 hr at 4TC, and the material between the pellet and lipid cap was recovered. The protein concentration of this extract was =8-10 mg/ml.
Assay for MPF Activity. Samples were assayed for MPF as presented in detail earlier (14) . One unit of MPF was defined as the amount of MPF in 70 nl that would cause maturation in 50%7o of the injected oocytes. The maximal-fold dilution (MFD) of the samples that allowed maturation of 50% of the injected oocytes was used to express relative MPF activity.
Assay of H1 Kinase Activity. H1 kinase activity in the solution was assayed by mixing 7.5 Al of sample with 2.5 .ul of H1 kinase assay reaction mixture at 220C for 30 min (14) . H1 kinase activity of the immunocomplexes on the affinity beads was assayed by mixing 15 Al of beads with 5 1d of the reaction mixture at 220C for 30 min. The proteins were then released from the beads by gel sample buffer. The samples were electrophoresed on a 12.5% polyacrylamide gel, and the phosphorylation of histone H1 was revealed by autoradiography.
Immunoblot Analysis. Sample proteins ,ul per lane) were separated on a 12.5% polyacrylamide gel, transblotted onto nitrocellulose, and immunostained according to Kuang et al. (14) . The PSTAIR polyclonal antiserum was from the laboratory of Paul Nurse (Oxford University). mAb MPM-2 ascites was produced as described (16) .
Immunoabsorption. IgGs from ascites were immobilized to Affli-Prep protein A beads (Bio-Rad) using the binding buffer from the MAPS II kit (Bio-Rad). Anti-frog cyclin B2 beads, p13sucl-Sepharose beads, and corresponding preimmune serum control beads were obtained from the laboratories ofTim Hunt (Cambridge University)-and Marc Kirschner (University of California, San Francisco). The beads were washed with EB and mixed with 1.5-2 vol of sample by rotation at 4°C for 3-4 hr. The depleted samples were obtained by pelleting the beads and recovering the supernatants. The beads were washed as reported (14) . The supernatants and/or beads were analyzed either for H1 kinase or by immunoblot.
Ultrogel AcA 34 Chromatography of Egg Extract. One milliliter of egg extract, which had an MFD of 4-6, was chromatographed on a 40-ml Ultrogel AcA -34 column (1.5 x 59 cm) preequilibrated with a column buffer (CB) that contained EB plus 1 mM dithiothreitol and 20 mM NaF, sup- . Onemilliliter fractions were collected at a flow rate of0.3 ml/min. After absorbance at 280 nm was determined for individual fractions, the flow-through (QF) and peak fractions of the 0.2 M NaCI (QE1) and 0.5 M NaCl (QE2) eluates were pooled separately. They were then dialyzed, concentrated, and assayed for MPF activity, H1 kinase activity (diluted 1:3 with EB), and PSTAIR antibody reactivity.
Bio-Gel A-1.5 m Chromatography of QF, QE1, and QE2. A volume of 0.5 ml containing pooled and concentrated QF, QE1, or QE2 from two-step Q-Sepharose chromatography (previously described) was chromatographed on a 20-ml Bio-Gel A-1.5 m column (0.9 x 53 cm) preequilibrated in CB (for QF) or CB-ATP[yS] (for QE1 and QE2). Fractions of0.5 ml were collected at a flow rate of 0.15 ml/min. Thyroglobulin (670 kDa), mouse IgG (150 kDa), and bovine serum albumin (68 kDa) were used as molecular size standards to calibrate the column.
RESULTS
Stabilization of MPF. MPF is notoriously unstable, especially during the early stages of purification. To ensure that we would not lose any major species of MPF during the investigation, we initially sought to define conditions under which MPF activity could be quantitatively recovered from gel filtration of unfertilized egg extract.
When extract was prepared with EB (15) , which stabilizes MPF activity in the extract for 24 hr at 40C, little MPF activity could be recovered after gel filtration. We 1D) . Therefore, the quantitative recovery of MPF could be achieved when thiophosphorylation was maximally favored. We consider the recovered MPF activity to be M phasespecific because no MPF activity could be recovered when immature oocyte extract was prepared and fractionated under similar conditions.
In the gel-filtration experiments described, the peak of recovered MPF activity was rather broad ( Fig. 1A ; fractions 18-34). Interestingly, when fresh extract was fractionated in CB-ATP, the highest level of MPF activity was in fractions [23] [24] (Fig. 1B) but shifted to fractions [26] [27] (Fig. 1C) when the column buffer contained ATP['yS] instead. However, when 3-day-old extract was fractionated in CBA-ATP[-yS], the maximum level of MPF activity extended from fractions [23] [24] [25] [26] (Fig. 1D) , including both high points. From these findings, it seemed that more than one factor might have contributed to the recovered MPF activity.
Relationship Bet*een MPF and cde2 Kinase Activity After Gel Filtration. After Ultrogel AcA 34 fractionation of egg extract, two prominent peaks of H1 kinase activity were detected, the first eluting near thyroglobulin (670 kDa) and the second near mouse IgG (150 kDa) (Fig. 1E) . The MPFpositive fractions extended from the trailing edge of the first H1 kinase peak (fraction 18) to the trailing edge of the second H1 kinase peak (fraction 34). Recently, we have demonstrated that only the second H1 kinase peak is cdc2 kinase (14) . The NaCl, whereas elution of the second peak began one to two fractions later at 0.2-0.3 M NaCl. We could clearly separate the two peaks of MPF activity by two successive elutionsthe first at 0.2 M NaCl (QE1) and the second at 0.5 M NaCl (QE2) (Fig. 2) . QE1 and QE2 each contained 40% of the recovered MPF activity, whereas the flow-through fraction (QF) contained 20%. Interestingly, when QF was dialyzed into EB without ATPlyS], its MPF activity remained stable, whereas the stability of MPF in QE1 and QE2 required ATP [yS] . At 40C QE1 lost all MPF activity within 24 hr, whereas the MPF activity in QE2 was stable for at least 3 days. When, however, QE1 and QE2 were coeluted by 0.5 M NaCl, the combined recovered MPF activity was as stable as that in QE2, suggesting that QE2 may stabilize the MPF in QEL. QF, QE1, and QE2 were individually fractionated on a Bio-Gel A-1.5 m column, chosen for its wider separation range, to estimate the apparent molecular size of the MPF, which differed in each fraction: -90 kDa in QF, :150 kDa in QE1, and =250 kDa in QE2. This difference explains why MPF activity eluted as a broad peak when the crude extract was fractionated by gel filtration.
Identifation of 61c2 Kinase-MPF. QF, QE1, and QE2 were assayed for H1 kinase activity and reactivity to the PSTAIR antibody, which recognizes the highly conserved domain of p34cdc*. On the average, -90% of total H1 kinase activity was recovered in QF, 9%o was recovered in QE1, and =z1% was recovered in QE2 (Fig. 3A) . The PSTAIR antibody-reactive protein was only detectable in QF (Fig.  3B) . To exclude the possibility that QEi and QE2 contained a level of the PSTAIR antibody-reactive protein too low for detection, we enriched p34cdc2 by p13 adsorption of fractions that had been concentrated =20-fold and analyzed the immobilized proteins. Again, the PSTAIR antibody-reactive protein was only detectable in QF, suggesting that cdc2 kinase was only present in QF (Fig. 3C) cyclin B2 affinity beads immobilized a high level of Hi kinase activity from QF, confirming that p34cdc2 is complexed with cyclin (data not shown).
To show that the MPF activity in QF was due to cdc2 kinase, QF was fractionated by Bio-Gel A-1.5 m chromatography, and the fractions were assayed for H1 kinase activity, MPF activity, and the PSTAIR antibody-reactive protein. As illustrated in Fig. 4 , the recovered MPF activity copurified with both H1 kinase activity and PSTAIR antibody-reactive protein. These results indicate that the MPF activity in QF is accounted for by p34cdc2-cyclin.
Identifiaton of MPM-2-Reactive MPF. MPM-2 is a mitosis-specific mAb that recognizes a family of phosphoproteins in M phase cells (16) . The fact that mAb MPM-2 immunodepletes MPF activity from egg extract but does not recognize the cdc2 kinase complex (14) suggested that mAb MPM-2 might recognize the MPF in QE1 or QE2. To explore this possibility, QF, QE1, and QE2 were incubated with mAb MPM-2 or control antibody (RDA-1) affinity beads for 3 hr, and the supernatants were assayed for MPF activity. Table 1 shows that while QF depleted by mAb MPM-2 contained similar levels of MPF activity as the control, QE1 and QE2 contained no detectable MPF activity after mAb MPM-2 depletion. Therefore, we conclude the MPF in both QE1 and QE2 is recognized by mAb MPM-2.
Proteins immobilized on the mAb MPM-2 immunoaffinity beads were assayed for their ability to phosphorylate histone H1 in vitro. mAb MPM-2-adsorbed protein from QF or QE1 showed no H1 kinase activity. However, a low level of H1 kinase activity was detected on mAb MPM-2 affinity beads after the adsorption of QE2 (data not shown). These results indicate that although the MPF in QE1 is not an H1 kinase, the MPF in QE2, which contained only 1% of total H1 kinase activity (see Fig. 3A ), could be weak H1 kinase. Finally, anticyclin beads depleted no MPF activity from either QE1 or QE2, indicating that cyclin B2 is unlikely to be a component of the MPF in QE1 or QE2.
Characterization of MPF in QF, QE1, and QE2. We found that QF, QE1, and QE2 each could induce oocyte maturation in the presence of cycloheximide and amplify MPF activity in recipient oocytes through successive transfers. We then tested whether each of the three fractions could simultaneously activate endogenous H1 kinase and MPF and cause expression of MPM-2 antigens, as is normally seen at the onset of M phase. QF, QE1, and QE2, as well as egg extract (positive control), were microinjected into Xenopus oocytes. Extracts were prepared from injected oocytes at 20-min intervals and assayed for H1 kinase activity, MPF activity, From each fraction, 7.5 ,ul was assayed for H1 kinase activity, 20 ,ul was analyzed for the PSTAIR antibody-reactive protein, and the rest was concentrated to 40 ,ul for assay of MPF activity (MFD). Elution positions of thyroglobulin (670 kDa) (arrow 1), mouse IgG (150 kDa) (arrow 2), and bovine serum albumin (68 kDa) (arrow 3) are indicated. (Fig. 5) . At 20 min after injection ofQF, QE2, and egg extract and 40 min after injection of QE1, MPF activity appeared concurrently with expression ofMPM-2 antigens as well as high levels of H1 kinase activity. Thus, within the limits of resolution in this time course study, each fraction could induce the simultaneous activation of H1 kinase and MPF and the expression of MPM-2 antigens. As illustrated in Fig. 5 , the levels of MPF activity induced in oocytes injected with QF, QE1, or QE2 were similar to that induced by egg extract, so that all three MPFs can activate the entire pool of latent forms of MPF in immature oocytes.
DISCUSSION
In this study, we developed a procedure by which MPF activity can be quantitatively recovered after gel filtration of unfertilized egg extract. The recovered MPF activity, which occurred as a rather broad peak, could be resolved into three fractions by Q-Sepharose chromatography (two-step elution). All three fractions can induce oocyte maturation independent of protein synthesis, activate endogenous H1 kinase and MPF, and induce the appearance of MPM-2 antigens in the oocyte. However, the MPF in each fiaction differs in apparent molecular mass, H1 kinase activity, the presence of the PSTAIR antibody-reactive protein, and stability at 4eC.
The MPF activity in QF is due to the cdc2 kinase complex. QF contains most of the H1 kinase activity, which can be immobilized by anti-cyclin B2 affinity beads and is strongly reactive to the PSTAIR antibody. When QF was fractionated by gel filtration, the recovered MPF activity copurified with both H1 kinase activity and the PSTAIR antibody-reactive (18) . The MPF activity in the okadaic acid-treated extract is probably due to the MPF present in QE1 and/or QE2.
Although the product of the protooncogene c-mos can induce oocyte maturation (19, 20) , it is not a likely candidate for MPF in QE1 or QE2 because it is newly synthesized during progesterone-induced oocyte maturation, whereas the full activation of MPF in immature oocytes can occur in the absence of c-mos protein synthesis (2, 17) . It is, therefore, likely that the c-mos protein functions as an upstream regulator ofMPF and contributes little, if any, to the MPF activity in unfertilized eggs. Xenopus cyclins also can induce maturation (21) (22) (23) and are a component of cdc2 kinase (24) . However, cyclin B2 is probably not a component of the MPF from QE1 or QE2 based on our immunodepletion studies. Whether other cyclins are components of the MPF in QE1 or QE2 remains to be established. Recently, the cdc25 gene product has been shown to have MPF activity (25) and be able to activate cdc2 kinase in vitro via dephosphorylation (26, 27) , which might account for the MPF in QE1 or QE2.
We have demonstrated that the mitosis-specific mAb MPM-2 can deplete the MPF activity from QE1 and QE2 but not from QF. This result may explain our previous finding that mAb MPM-2 depletes MPF activity from Xenopus egg extract (13) , although it does not recognize cdc2 kinase (14) . Additionally, as described by Davis et al. (16) , mAb MPM-2 reacts with a distinct set of proteins once they are phosphorylated during the G2/M transition. Therefore, mAb MPM-2 recognition of the MPFs in QE1 and QE2 indicates that they have undergone this mitosis-specific phosphorylation. It is possible that the phosphorylation recognized by mAb MPM-2 is essential for activating the MPFs in QE1 and QE2. This result would explain why reagents that favor phosphoproteins in their phosphorylated state promote MPF stability (17) .
Upon microinjection into Xenopus oocytes, QE1 and QE2 activate the endogenous M phase-specific H1 kinase. Because we have shown that cdc2 kinase contributes to =80% of the M phase-specific Hi1 kinase activity in Xenopus oocytes (14) , we can conclude that both QE1 and QE2 can activate cdc2 kinase directly or indirectly. Our data showed that QE2 may stabilize the MPF activity in QEL. These results suggest that QF (cdc2-cyclin), QE1, and QE2 may form a regulatory loop that together can account for MPF activity.
